HUS

FSIS ISSUES PUBLIC HEALTH ALERT FOR GROUND BEEF PRODUCTS DUE TO POSSIBLE E. COLI O157:H7 CONTAMINATION

Retrieved on: 
Samstag, April 20, 2024
Food safety, Syndrome, Person, Poultry, Dysentery, Independence Avenue, Commerce, Kidney failure, USDA, Human, H7, Dehydration, HUS, TDD, Pallor, Meat, Temperature, Chronic pain, FSIS, Bruise, Office for Civil Rights, Civil and political rights, Poultry farming

WASHINGTON, April 20, 2024 – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for ground beef products that may be contaminated with E. coli O157:H7.

Key Points: 
  • WASHINGTON, April 20, 2024 – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for ground beef products that may be contaminated with E. coli O157:H7.
  • FSIS is issuing this public health alert to ensure that consumers are aware that these products should not be consumed.
  • The products have a “Use/Freeze by” date of April 22, 2024, and packaging date of “032824.” The list of products that are subject to the public health alert can be found here .
  • The company notified FSIS that they inadvertently used a portion of the contaminated beef to produce ground beef products that they subsequently shipped into commerce.

Ron Simon & Associates Files Nation's First E.coli Lawsuit Against Brigantine Inc. for the E. Coli Outbreak Linked to Miguel's Cocina in San Diego

Retrieved on: 
Donnerstag, Oktober 26, 2023
Meal, Escherichia coli, HUS, Syndrome, 1992–1993 Jack in the Box E. coli outbreak, Hospital, UC San Diego Health, SAN, Poultry farming, Cocina

According to the San Diego Health and Human Services (SDHHS) there have been 15 victims identified thus far, including at least 7 requiring hospitalization.

Key Points: 
  • According to the San Diego Health and Human Services (SDHHS) there have been 15 victims identified thus far, including at least 7 requiring hospitalization.
  • SDHHS has identified Miguel's Cocina 45 Ranch, located at 10514 Craftsman Way, in San Diego, as the source of the outbreak, implicating meals eaten between October 6th through the 18th.
  • The lawsuit was filed against Brigantine Inc. in San Diego County, California on behalf of Mary Margaret Dowd, one of the victim's requiring hospitalization.
  • Mr. Simon and his law firm have established an E. coli Claim Center to assist victims in the outbreak.

MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures

Retrieved on: 
Montag, September 25, 2023
Health, Surgery, Health Technology, Other Health, General Health, Biotechnology, HUS, Surgeon, Tremor, Freedom, University Hospitals Cleveland Medical Center, Quality of life, Head, ZEUS robotic surgical system, Hospital, Lymphedema, MD, Patient, European, Microsurgery, Filtration, Robotics, Trauma, MMI, 500th, Dentistry, Nursing, Doctor of Philosophy

The Symani Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery.

Key Points: 
  • The Symani Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery.
  • It is a robotic platform that enables expanded options for patients in need of soft tissue open surgical procedures, such as free flap reconstructions, lymphatic surgery, trauma reconstructions, and peripheral nerve repairs.
  • Since the first in-human cases in October 2020, the system has been used in over 500 procedures, rapidly increasing patient access to surgical treatment options as surgeons become comfortable using the technology.
  • Of the 500 procedures completed to date, approximately 75 percent have been free flap surgeries, and 16 percent have been lymphatic repairs.

University of Arkansas E. coli Outbreak Investigated by The Lange Law Firm

Retrieved on: 
Samstag, August 26, 2023
Taste, Smell, HUS, Ill, Kidney failure, Food, University, Student, Arkansas Department of Health, Infection, Hemolytic–uremic syndrome, Escherichia coli, Hemolysis, History, H7, Restaurant, University of Arkansas, Family, Nursing, Poultry farming

FAYETTEVILLE, Ark., Aug. 26, 2023 /PRNewswire/ -- Authorities are racing to determine the source of an E. coli outbreak in which nearly 100 University of Arkansas students and staff may have contracted E. coli.

Key Points: 
  • FAYETTEVILLE, Ark., Aug. 26, 2023 /PRNewswire/ -- Authorities are racing to determine the source of an E. coli outbreak in which nearly 100 University of Arkansas students and staff may have contracted E. coli.
  • E. coli infections can cause a type of acute kidney failure called Hemolytic uremic syndrome or "HUS".
  • It occurs in about 10% of those who become infected with O157: H7 or any other Shiga toxin-producing E. coli.
  • The University of Arkansas and the Arkansas Department of Health are trying to identify the source of the University of Arkansas Ecoli outbreak , which they believe started more than a week ago.

Hubbell Announces New Segment Leadership

Retrieved on: 
Mittwoch, Juni 7, 2023
Acceleration, HUS, Hubbell, Eaton Corporation, HES, HPS, Retirement, Acquisition, Rockwell Automation, Growth, NYSE, Playbook, Management, Renewable energy, Aclara Biosciences

Shelton, CT, June 7, 2023 - Hubbell Incorporated (NYSE: HUBB) (“Hubbell” or the “Company”) today announced that Allan Connolly, President of Hubbell Utility Solutions (“HUS”), will retire effective July 1, 2023.

Key Points: 
  • Shelton, CT, June 7, 2023 - Hubbell Incorporated (NYSE: HUBB) (“Hubbell” or the “Company”) today announced that Allan Connolly, President of Hubbell Utility Solutions (“HUS”), will retire effective July 1, 2023.
  • The Company further announced today the appointment of Mark Mikes as President of the Hubbell Electrical Solutions (“HES”) segment.
  • I look forward to him joining Hubbell’s leadership team.”
    Mark Mikes has been with Hubbell for over thirty years in various roles at Hubbell Power Systems (“HPS”), a division of HUS, which he has led for the last several years.
  • Hubbell is excited to announce today the appointments of our new segment leaders.

lēf Farms Recalls"Spice" Packaged Salad Greens Because of Possible Health Risk

Retrieved on: 
Freitag, Mai 5, 2023
HUS, Kidney failure, Blood, New Hampshire Department of Agriculture, Markets, and Food, UPC, Escherichia coli, Multimedia, Kidney, EDT, Food and Drug Administration, H7, Bacteria, FDA, Death, Food, Hemolytic–uremic syndrome, New Hampshire Department of Corrections, Poultry farming, Online shopping

According to the Food and Drug Administration (FDA) , E. coli causes a diarrheal illness often with bloody stools.

Key Points: 
  • According to the Food and Drug Administration (FDA) , E. coli causes a diarrheal illness often with bloody stools.
  • Although most healthy adults can recover completely within a week, some people can develop a form of kidney failure called Hemolytic Uremic Syndrome (HUS).
  • The recall was initiated when the New Hampshire Department of Agriculture received a positive test result for E. coli 0157:H7 in a single package of lēf Farms "Spice" Packaged Salad Greens (4-oz.)
  • lēf Farms "Spice" is the only product impacted to date and affected retailers include Hannaford and Market Basket in Maine, Massachusetts, New Hampshire, New York, Rhode Island and Vermont.

Meridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay

Retrieved on: 
Mittwoch, April 19, 2023
HUS, STEC, Human, Subjectivity, Workflow, Syndrome, Infection, Campylobacter, Shiga toxin, STX1A, Patient, LIS, FDA, GI, Pharmaceutical industry, Meridian

CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.

Key Points: 
  • CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.
  • This assay joins Curian HpSA® and Curian Campy as Meridian expands its Curian diagnostic platform to maintain leadership in the gastrointestinal disease testing market.
  • The Curian Shiga Toxin assay is designed for use with the Curian analyzer.
  • The new assay is a rapid, qualitative, fluorescent immunoassay for the simultaneous detection and differentiation of Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2) in a single test device.

Global E. Coli Testing Markets Report 2022: A $2.8 Billion Market by 2027 - Industry Trends, Opportunities and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Freitag, Dezember 30, 2022
Medical Devices, Health, Bacteria, Research, Water, COVID-19, Diarrhea, Escherichia coli, Vegetable, Microdeletion syndrome, Enzyme, Microbiology, Degenerative disease, R, HUS, Drinking water, Prevalence, Cheese, Poultry, Pharmaceutical industry, Potash, Growth

The "E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global E. coli testing market size reached US$ 1.8 Billion in 2021.
  • Looking forward, the market is set to reach US$ 2.8 Billion by 2027, exhibiting a CAGR of 7.64% during 2021-2027.
  • What is the structure of the global E. coli testing market and who are the key players?

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Retrieved on: 
Dienstag, November 22, 2022
Biotechnology, Neurology, Health, Pharmaceutical, Oncology, Immunotherapy, PFS, MMR, Temozolomide, Education, Versata Development Group, Inc. v. SAP America, Inc., COSMIC, MSH6, ARID1A, CBM, Survival, Software, Neoplasm, Anomaly, Principal, Cell death, GBM, HUS, TCGA, EP300, Mutation, Neuro, Drug combination, DNA, DNA mismatch repair, Agilent Technologies, Lomustine, Biosimulation, MLH1, Survivor, Biomarker, Glioblastoma, Apoptosis, Research, Progression-free survival, TMZ, Society, Physician, Partial, Sequoia Capital, MGMT, CREBBP, EXO1, MSI, IDH, Kali Mutsa, OS, UnitedHealth Group, Gene, Patient, Pharmaceutical industry, Vaccine, MRD

The biosimulation study validated that TMZ does not trigger apoptosis in mismatch repair deficiency cancers and uncovered promising new biomarkers for TMZ resistance.

Key Points: 
  • The biosimulation study validated that TMZ does not trigger apoptosis in mismatch repair deficiency cancers and uncovered promising new biomarkers for TMZ resistance.
  • In fact, Cellworks biosimulation identifies MMR deficiency due to epigenetic, translational and proteomic silencing that leads to early progression on temozolomide despite methylated MGMT.
  • The purpose of the study was to examine the impact of mismatch repair deficiency (MRD) on survival of temozolomide (TMZ)-treated patients with MGMT methylated (m-MGMT) glioblastoma (GBM) using Cellworks computational biosimulation.
  • The Cellworks Platform predicts therapy response for individual patients and patient cohorts using a breakthrough Computational Biology Model (CBM) and biosimulation technology.

BC Platforms Partners with EU Funded, AI-Driven, Cancer Data Initiative

Retrieved on: 
Donnerstag, November 24, 2022
Hospital, R, European Commission, MIT, Partnership, HUS, European Union's scientific cooperation beyond the bloc, HTA, European Commission Investment Plan for Europe, Collection, Medicine, EC, Research, Integrated collaboration environment, Health technology assessment, RWE, BCP, Pharmacy, Health, Data analysis, Patient, Medical imaging, Pharmaceutical industry, Oncology

It does this by standardising data processing in hospitals enabling them to efficiently measure the cost effectiveness of new cancer therapies for Health Technology Assessment (HTA) and regulatory purposes.

Key Points: 
  • It does this by standardising data processing in hospitals enabling them to efficiently measure the cost effectiveness of new cancer therapies for Health Technology Assessment (HTA) and regulatory purposes.
  • I'm proud our sophisticated healthcare data management and analytics products have been recognised by this significant, four-year, Horizon Europe project.
  • BC Platforms is a global leader in building data networks for the life sciences industry and provides versatile technology platforms for personalised medicine, accelerating the translation of innovations into clinical practice.
  • We have developed a Global Data Partner Network, BCRQUEST.com, which allows access to high-quality real-world data.